Diffuse hyperintense brainstem lesions in neuroborreliosis.
Haene
Adrian
A
Department of Neurology, Cantonal Hospital Aarau, Tellstrasse, 5001 Aarau, Switzerland. adrian.haene@swissonline.ch
Tröger
Mathias
M
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001933:Brain Stem / Q000382:microbiology* / Q000473:pathology* / Q000503:physiopathology; D002443:Ceftriaxone / Q000627:therapeutic use; D002526:Cerebellar Diseases / Q000382:microbiology / Q000473:pathology / Q000503:physiopathology; D003937:Diagnosis, Differential; D004027:Diencephalon / Q000382:microbiology / Q000473:pathology / Q000503:physiopathology; D018450:Disease Progression; D005221:Fatigue / Q000209:etiology; D005260:Female; D006801:Humans; D020852:Lyme Neuroborreliosis / Q000276:immunology / Q000473:pathology* / Q000503:physiopathology; D008279:Magnetic Resonance Imaging; D008636:Mesencephalon / Q000382:microbiology / Q000473:pathology / Q000503:physiopathology; D008875:Middle Aged; D019547:Neck Pain / Q000209:etiology; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D002443:Ceftriaxone